Beauty

Shiseido to Sell China's Aupres Business to IDG-Led Consortium

Linnea NordvikNovember 19, 20265 min read0 views

At a glance

  • The Japanese beauty group will transfer its Shiseido Liyuan subsidiary, including the Aupres brand and Beijing factory, as part of a profitability and capital-efficiency drive.
  • Shiseido has agreed to sell its Chinese subsidiary Shiseido Liyuan Cosmetics to an IDG Capital-led investor group, with closing expected between late 2026 and early 2027. The divestment is intended to focus resources on priority brands and higher-growth opportunities while supporting Aupres through a transition period.
A cosmetic bottle and cream jar stand before a factory and city skyline, with abstract forms suggesting a business handover.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to a consortium led by Hong Kong-based private equity firm IDG Capital. SLC manufactures and sells the Aupres brand in China. The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China. Financial terms were not disclosed.

The sale is part of Shiseido's effort to improve profitability and capital efficiency under its 2030 Medium-Term Strategy. The company said the plan is aimed at sustainable growth and stronger competitiveness in China by concentrating management resources on areas where it has the greatest competitive advantage. Shiseido described the SLC business as requiring continued investment in product innovation and digital capabilities. By divesting it, the group intends to focus on priority brands and higher-growth opportunities.

Shiseido said China remains a strategically important market and described it as attractive and dynamic, with a competitive landscape that continues to change as e-commerce expands, consumer behavior shifts and diverse market participants emerge.

Joint venture background

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. SLC has sold the C-beauty brand Aupres since 1994. The existing joint venture agreement was due to expire in December 2026, and the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan's 35% stake, giving it full ownership before the sale.

Ownership and transition

Under the transaction, funds managed by IDG Capital will hold 95% of the equity through two special purpose vehicles. A limited partnership set up mainly by SLC's new management team will hold the remaining 5%. The deal includes SLC's Beijing factory and production equipment.

Shiseido said independent operation under IDG should support SLC's sustainable growth and brand value. To help ensure a smooth handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer, Shiseido will also provide support on new product development, technical assistance for stable supply of existing products, and continued supply of raw materials and selected products. Shiseido said the transitional collaboration is intended to maintain SLC's innovation capabilities, product quality and business continuity.

Profit recovery context

The sale comes days after Shiseido reported a 124.3% increase in core operating profit for the third quarter of 2026, to ¥67.5 billion, or about US$422.13 million. The company attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales rose 0.7%. Shiseido raised its full-year core operating profit forecast from ¥59 billion, or about US$433 million, to ¥87 billion, or about US$546 million, following those results.

Reported by Linnea Nordvik, Salon Equipment and Beauty Tools Writer.